Company Quick10K Filing
Immune Therapeutics
10-Q 2020-09-30 Filed 2020-11-16
10-Q 2020-06-30 Filed 2020-08-14
10-Q 2020-03-31 Filed 2020-06-29
10-K 2019-12-31 Filed 2020-05-14
10-Q 2019-09-30 Filed 2019-11-19
10-Q 2019-06-30 Filed 2019-08-14
10-Q 2019-03-31 Filed 2019-05-20
10-K 2018-12-31 Filed 2019-04-16
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-15
10-K 2017-12-31 Filed 2018-04-02
10-Q 2017-09-30 Filed 2017-11-14
10-Q 2017-06-30 Filed 2017-08-14
10-Q 2017-03-31 Filed 2017-05-12
10-K 2016-12-31 Filed 2017-03-31
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-15
10-Q 2016-03-31 Filed 2016-05-16
10-K 2015-12-31 Filed 2016-03-30
10-Q 2015-09-30 Filed 2015-11-16
10-Q 2015-06-30 Filed 2015-08-14
10-Q 2015-05-13 Filed 2015-05-15
10-K 2014-12-31 Filed 2015-03-31
10-Q 2014-09-30 Filed 2014-11-14
10-Q 2014-06-30 Filed 2014-08-14
10-Q 2014-03-31 Filed 2014-05-15
10-K 2013-12-31 Filed 2014-03-31
10-Q 2013-09-30 Filed 2013-11-14
10-Q 2013-06-30 Filed 2013-08-13
10-Q 2013-03-31 Filed 2013-05-15
8-K 2020-10-20
8-K 2020-08-16
8-K 2020-07-22
8-K 2020-05-14
8-K 2020-04-29
8-K 2020-03-20
8-K 2020-02-27
8-K 2020-02-14
8-K 2019-10-25
8-K 2019-09-20
8-K 2019-05-30
8-K 2019-05-15
8-K 2019-01-02
8-K 2018-06-04
8-K 2018-04-26
8-K 2018-04-17
8-K 2018-03-26

Immune Therapeutics Financials

IMUN Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI) 0% 1,546,418 322,654 0 0 0 0 -853,740
1 800 Flowers Com (FLWS) 944,324 42% 13.3 6% 664,955 335,559 1,266,390 533,727 36,761 75,090 1,000,932
10x Genomics (TXG) 4,804,979 75% -490.3 -2% 572,815 151,367 61,207 45,727 -9,603 -8,887 4,357,180
12 Retech (RETC) 0 32% -0.1 -1,385% 1,118 20,421 625 199 -15,491 -14,800 966
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH) 33,711 0% 0.4 -5% 164,088 108,405 18,194 0 -7,969 -8,017 -2,855
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH) 25% -2.4 -15% 18,527 23,194 27,219 6,699 -2,862 -1,433 3,396
1895 Bancorp of Wisconsin (BCOW) 46,152,715 12,508.1 -0% 441,187 382,722 0 0 -44 3,689 46,142,359
1st Constitution Bancorp (FCCY) 164,504 0% 4.4 1% 1,342,565 1,204,038 490 0 13,787 32,503 143,748
1st Franklin Financial (FFC) 3,551 -0.6 7% 905,107 644,730 0 0 62,078 80,004 -45,962
24 7 Kid Doc (TVMD)
1st Source (SRCE) 1,200,033 7.9 1% 6,691,070 5,858,028 0 0 70,061 136,342 1,072,548
2050 Motors (ETFM) 0 -0.2 -166,272,400% 0 1,849 0 0 -1,663 -1,654 250
21Vianet Group (VNET) 6,005,116 0% 11,150,717 5,787,533 0 0 0 0 3,344,095
22nd Century (XXII) 301,854 1% -14.1 -36% 61,864 6,554 25,706 304 -22,433 -21,464 301,826
1Life Healthcare (ONEM)

Balance Sheet ($'000)2013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-05-132015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash176231208407234595919231221542313364227498452315300666216
Accounts Receivable28131620300
Inventory214178159159159838300
PP&E2356565443221102233344313131313
Assets21,02120,26019,54019,19218,11917,31716,6126,0555,7475,5965,63141155792376100482401961931641689291248
Accounts Payable3624386308401,0121,6481,8032,0771,8851,9181,9241,9251,8601,5181,5171,8191,6661,7952,2232,3202,4121,6891,5332,0652,0222,1482,275
Long-Term Debt3271,0141,4571,8382,7942,8383,457000
Liabilities2,0072,3352,5242,5613,3374,0502,7273,7034,0444,3754,6955,9996,3407,0067,4889,20110,3897,9068,59411,29911,3529,77110,88711,34211,84612,55313,479
Stockholders' Equity19,01517,92517,01616,63114,78213,26813,8841,746973877758-5,929-4,041-4,672-5,203-5,134-6,162-3,599-3,878-6,495-6,429-9,607-10,719-11,251-11,755-13,471
Income Statement ($'000)2013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-05-132015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue0000000026543000000065650000
Cost of Revenue3300000
Gross Profit3200000
R&D3808,7126,4186,5144,1712,026401941177414111274-196724714911913410937129760000
SG&A1,67719,23412,60837,64212,6133,7269028084024448651,0459398941,0311,0226665566219896381,137588487497389
Tax000000
Net Income-14,690-24,678-19,946-46,746-17,665-4,307-11,202-14,484-2,905-2,591-4,025-7,450-6,645-4,039-3,944-5,191-2,7061,387-1,600-3,777-732-4,348-2,602-709-825-941
Cash Flow ($'000)2013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-05-132015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-1,183-1,545-1,728-2,115-1,360-1,201-528-754-757-508-639-929-598-802-934-506-529-702-384-438-456-414-55-016-15
Cash Investing-162-2-1-10-43-574100000-20-200-2-120000
Cash Financing1,2081,6021,7062,3151,1871,06858684659650077079870773489256055365036243047339660000